Login / Signup

Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods.

Liza JózsaDániel NemesÁgota PetőDóra KósaRéka RévészIldikó BácskayÁdám HaimhofferGábor Vasvári
Published in: Pharmaceutics (2023)
Bioavailability assessment in the development phase of a drug product is vital to reveal the disadvantageous properties of the substance and the possible technological interventions. However, in vivo pharmacokinetic studies provide strong evidence for drug approval applications. Human and animal studies must be designed on the basis of preliminary biorelevant experiments in vitro and ex vivo. In this article, the authors have reviewed the recent methods and techniques from the last decade that are in use for assessing the bioavailability of drug molecules and the effects of technological modifications and drug delivery systems. Four main administration routes were selected: oral, transdermal, ocular, and nasal or inhalation. Three levels of methodologies were screened for each category: in vitro techniques with artificial membranes; cell culture, including monocultures and co-cultures; and finally, experiments where tissue or organ samples were used. Reproducibility, predictability, and level of acceptance by the regulatory organizations are summarized for the readers.
Keyphrases
  • endothelial cells
  • adverse drug
  • physical activity
  • drug induced
  • case control
  • transcription factor
  • genome wide
  • gene expression
  • emergency department
  • optical coherence tomography
  • clinical evaluation